As of May 2024 MannKind Corp has a market cap of $1.24 Billion. This makes MannKind Corp the world's 4893th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.24 B | 27.38% |
2023 | $0.98 B | -29.26% |
2022 | $1.38 B | 26.33% |
2021 | $1.09 B | 48.85% |
2020 | $0.73 B | 169.99% |
2019 | $0.27 B | 37.81% |
2018 | $0.19 B | -28.11% |
2017 | $0.27 B | -9.46% |
2016 | $0.30 B | -51% |
2015 | $0.62 B | -70.65% |
2014 | $2.11 B | 10.24% |
2013 | $1.92 B | 190.71% |
2012 | $0.66 B | 101.23% |
2011 | $0.32 B | -68.12% |
2010 | $1.03 B | 4.03% |
2009 | $0.99 B | 182.98% |
2008 | $0.34 B | -56.64% |
2007 | $0.80 B | -33.29% |
2006 | $1.20 B | 231.67% |
2005 | $0.36 B | -28.51% |
2004 | $0.51 B |
On May 19th, 2024 the market cap of MannKind Corp was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Pfizer PFE | $162.29 B | 12,884.01% | ๐บ๐ธ USA |
Novo Nordisk NVO | $587.54 B | 46,906.52% | ๐ฉ๐ฐ Denmark |
Eli Lilly LLY | $731.81 B | 58,448.21% | ๐บ๐ธ USA |
Merck MRK | $332.27 B | 26,483.83% | ๐บ๐ธ USA |
Halozyme Therapeutics HALO | $5.69 B | 355.26% | ๐บ๐ธ USA |
Nektar Therapeutics
NKTR | $0.32 B | -74.22% | ๐บ๐ธ USA |